Matches in Wikidata for { <http://www.wikidata.org/entity/Q74281882> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q74281882 description "clinical trial" @default.
- Q74281882 description "ensayu clínicu" @default.
- Q74281882 description "klinisch onderzoek" @default.
- Q74281882 description "клінічне випробування" @default.
- Q74281882 name "A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis" @default.
- Q74281882 name "A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis" @default.
- Q74281882 type Item @default.
- Q74281882 label "A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis" @default.
- Q74281882 label "A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis" @default.
- Q74281882 prefLabel "A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis" @default.
- Q74281882 prefLabel "A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis" @default.
- Q74281882 P1050 Q74281882-9D650927-A3DB-4F67-8A91-01038D3F2C30 @default.
- Q74281882 P1050 Q74281882-E81B4EF0-78FA-4806-BD68-515A815485C6 @default.
- Q74281882 P1132 Q74281882-4C81C2D8-D979-43B1-BDE6-50F9EB9454FE @default.
- Q74281882 P1476 Q74281882-F97E0117-7D5F-4214-9C83-6E49234F0D2B @default.
- Q74281882 P17 Q74281882-5800C242-EB28-42F5-A55C-253BB5D05817 @default.
- Q74281882 P2899 Q74281882-2C093B32-712F-4646-96DD-B4C40B0A9238 @default.
- Q74281882 P3098 Q74281882-F1BB5EF7-F0D5-46F9-9107-8ABB168CA30A @default.
- Q74281882 P31 Q74281882-20F34B93-0DFA-4CBF-89CA-DA5DF69F9DC3 @default.
- Q74281882 P580 Q74281882-3592D6C0-0F8E-48C9-83FF-21C19509BB1A @default.
- Q74281882 P582 Q74281882-19F99D91-4707-45B7-BF15-1DA8619E4FAC @default.
- Q74281882 P6099 Q74281882-B95803E8-EAB2-4A81-A534-97D50D8F1436 @default.
- Q74281882 P8363 Q74281882-4A0A50A2-3D21-4F98-A8C3-3C16FAE43CD5 @default.
- Q74281882 P1050 Q229256 @default.
- Q74281882 P1050 Q988594 @default.
- Q74281882 P1132 "+50" @default.
- Q74281882 P1476 "A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis" @default.
- Q74281882 P17 Q334 @default.
- Q74281882 P2899 "+18" @default.
- Q74281882 P3098 "NCT04090229" @default.
- Q74281882 P31 Q30612 @default.
- Q74281882 P580 "2019-09-30T00:00:00Z" @default.
- Q74281882 P582 "2020-10-31T00:00:00Z" @default.
- Q74281882 P6099 Q5452194 @default.
- Q74281882 P8363 Q78089383 @default.